Buy FEMARA 5 Online

Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;
Formula: C17H11N5
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

FEMARA 5mg – PARA PHARMA

Femara, with the active ingredient letrozole, is a prescription medication primarily used in the treatment of hormone receptor-positive breast cancer. It belongs to a class of drugs known as aromatase inhibitors. Letrozole works by reducing the levels of estrogen in postmenopausal women, which can help slow down or inhibit the growth of certain types of breast tumors that depend on estrogen for their development.

Key Points:

• Mechanism of Action: Letrozole inhibits the activity of the aromatase enzyme, which is responsible for the conversion of androgens (male hormones) into estrogen (female hormone). By reducing estrogen levels, it helps suppress the stimulation of estrogen-sensitive breast cancer cells.
• Indications: Femara is commonly prescribed for postmenopausal women with hormone receptor-positive early breast cancer following surgery or for advanced breast cancer. It may also be used in certain fertility treatments to stimulate ovulation.
• Formulation and Dosage: Femara is typically available in tablet form for oral administration. The dosage and duration of treatment are determined by the treating oncologist or healthcare provider based on the specific condition being treated.
• Usage in Breast Cancer Treatment: Femara is often used as an adjuvant therapy (additional treatment) in postmenopausal women to reduce the risk of breast cancer recurrence. It may also be used as a first-line or subsequent treatment for advanced breast cancer.
• Fertility Treatment: In some cases, Femara may be prescribed off-label for fertility treatments, particularly in women with ovulatory issues.
• Precautions and Side Effects: Common side effects may include hot flashes, joint pain, fatigue, and increased sweating. It’s important for patients to report any unusual or severe side effects to their healthcare provider. Due to its impact on estrogen levels, Femara is generally not prescribed for premenopausal women.
• Monitoring and Follow-up: Regular monitoring, including bone density assessments, may be recommended during Femara treatment due to potential impacts on bone health.
• Interaction with Other Medications: Femara may interact with certain medications, so it’s essential for patients to inform their healthcare provider about all the medications they are taking, including over-the-counter drugs and supplements.

As with any prescription medication, it’s crucial to follow the healthcare provider’s instructions regarding dosage, administration, and potential side effects. For personalized information and guidance, individuals should consult with their healthcare professionals.